Refereed Journal Articles


Lotan, A., Luza, S., Opazo, C. M., Ayton, S., Lane, D. J. R., Mancuso, S., Pereira, A., Sundram, S., Weickert, C. S., Bousman, C., Pantelis, C., Everall, I. P., & Bush, A. I. (2023). Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular Psychiatry.


Brennan, E., Dunstone, K., Vittiglia, A., Mancuso, S., Durkin, S., Slater, M. D., Hoek, J., Pettigrew, S., & Wakefield, M. (2022). Testing the effectiveness of alcohol health warning label formats: An online experimental study with Australian adult drinkers. PloS one, 17(12), e0276189.


Jenkins, Z. M., Mancuso, S. G., Phillipou, A., & Castle, D. J. (2021). What is OSFED? The predicament of classifying ‘other’ eating disorders. BJPsych Open, 7(5), e147, Article e147.

Laskaris, L., Mancuso, S., Shannon Weickert, C., Zalesky, A., Chana, G., Wannan, C., Bousman, C., Baune, B. T., McGorry, P., Pantelis, C., & Cropley, V. L. (2021). Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder. Brain, Behavior, and Immunity, 95, 299-309.

Mancuso, S., Brennan, E., Dunstone, K., Vittiglia, A., Durkin, S., Thrasher, J. F., Hoek, J., & Wakefield, M. (2021). Australian Smokers’ Sensory Experiences and Beliefs Associated with Menthol and Non-Menthol Cigarettes. International Journal of Environmental Research and Public Health, 18(11), 5501.

Sabates, J., Belleville, S., Castellani, M., Dwolatzky, T., Hampstead, B. M., Lampit, A., Simon, S., Anstey, K., Goodenough, B., Mancuso, S., Marques, D., Sinnott, R., & Bahar-Fuchs, A. (2021). CogTale: an online platform for the evaluation, synthesis, and dissemination of evidence from cognitive interventions studies. Systematic Reviews, 10(1), 236.


Simhan, S., Thijs, V., Mancuso, S., Tsivgoulis, G., Katsanos, A., Alexandrov, A. V., & Kanaan, R. A. (2020). The outcome of acute functional neurological disorder: a meta-analysis of stroke-mimic presentations. Journal of Neurology, 267(5), 1353-1357.


Bousman, C. A., Arandjelovic, K., Mancuso, S. G., Eyre, H. A., & Dunlop, B. W. (2019). Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomised controlled trials. Pharmacogenomics, 20(1), 37-47.

Bousman, C. A., Luza, S., Mancuso, S. G., Kang, D., Opazo, C. M., Mostaid, M. S., Cropley, V., McGorry, P., Shannon Weickert, C., Pantelis, C., Bush, A. I., & Everall, I. P. (2019). Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia. Scientific Reports, 9(1), 2307.

Ferdowsi, N., Huq, M., Stevens, W., Hudson, M., Wang, M., Tay, T., Burchell, J. L., Mancuso, S., Rabusa, C., Sundararajan, V., Prior, D., Proudman, S. M., Baron, M., Nikpour, M., Scleroderma Clinical Trials Consortium Damage Index Working Group. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases, 78(6), 807-816.

Liu, C., Kanazawa, T., Tian, Y., Mohamed Saini, S., Mancuso, S., Mostaid, M. S., Takahashi, A., Zhang, D., Zhang, F., Yu, H., Doo Shin, H., Sub Cheong, H., Ikeda, M., Kubo, M., Iwata, N., Woo, S. I., Yue, W., Kamatani, Y., Shi, Y., Li, Z., Everall, I., Pantelis, C., & Bousman, C. (2019). The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies. Transl Psychiatry, 9(1), 205.

Meiklejohn, H., Mostaid, M. S., Luza, S., Mancuso, S. G., Kang, D., Atherton, S., Rothmond, D. A., Weickert, C. S., Opazo, C. M., Pantelis, C., Bush, A. I., Everall, I. P., & Bousman, C. A. (2019). Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia. Journal of Psychiatric Research, 113, 51-57.

Miller, K., Mancuso, S., Tacey, M., Walterfang, M., Velakoulis, D., & Hitch, D. (2019). The capacity of the BATCH as a predictive tool for discharge planning for people with neuropsychiatric disorders. Australian Occupational Therapy Journal, 66(2), 193-200.

Murnane, A., Thompson, K., Mancuso, S. G., Lewin, J., & Orme, L. M. (2019). Exploring the effect of exercise physiology intervention among adolescent and young adults diagnosed with cancer. Rehabilitation Oncology, 37(2), 55-63.

Saini, S. M., Mancuso, S., Liu, C., Mostaid, M. S., Cropley, V., Van Rheenen, T., Everall, I. P., Bousman, C., & Pantelis, C. (2019). Corrigendum to SU115 Interaction effects of childhood adversity and glutamatergic polygenic risk score on brain structure and cognition in schizophrenia. European Neuropsychopharmacology, 29, S1268–S1342.

Smith, A., Murnane, A., Thompson, K., & Mancuso, S. (2019). ReActivate—A Goal-Orientated Rehabilitation Program for Adolescent and Young Adult Cancer Survivors. Rehabilitation Oncology, 37(4), 153-159.

Wannan, C. M. J., Cropley, V. L., Chakravarty, M. M., Van Rheenen, T. E., Mancuso, S., Bousman, C., Everall, I., McGorry, P. D., Pantelis, C., & Bartholomeusz, C. F. (2019). Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder. Psychol Med, 49(14), 2452-2462.


Hocking, D. C., Mancuso, S. G., & Sundram, S. (2018). Development and validation of a mental health screening tool for asylum-seekers and refugees: the STAR-MH. BMC psychiatry, 18(1), 69.

Hoffmann, C., Van Rheenen, T. E., Mancuso, S. G., Zalesky, A., Bruggemann, J., Lenroot, R. K., Sundram, S., Weickert, C. S., Weickert, T. W., Pantelis, C., Cropley, V., & Bousman, C. A. (2018). Exploring the moderating effects of dopaminergic polymorphisms and childhood adversity on brain morphology in schizophrenia-spectrum disorders. Psychiatry Res Neuroimaging, 281, 61-68.


Mostaid, M., Mancuso, S., Liu, C., Sundram, S., Pantelis, C., Everall, I., & Bousman, C. (2017). Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia. Translational Psychiatry, 7(1), e1004-e1004.

Saini, S., Mancuso, S., Mostaid, M. S., Liu, C., Pantelis, C., Everall, I., & Bousman, C. (2017). Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Translational Psychiatry, 7(8), e1196-e1196.


Bosanac, P., Mancuso, S. G., & Castle, D. J. (2016). Anxiety Symptoms in Psychotic Disorders: Results from the Second Australian National Mental Health Survey. Clin Schizophr Relat Psychoses, 10(2), 93-100.

Mancuso, S. G. (2016). Body image inflexibility mediates the relationship between body image evaluation and maladaptive body image coping strategies. Body Image, 16(1), 28-31.

Neilson, K., Ftanou, M., Monshat, K., Salzberg, M., Bell, S., Kamm, M. A., Connell, W., Knowles, S. R., Sevar, K., Mancuso, S. G., & Castle, D. (2016). A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 22(3), 694-701.

O’Brien, C. L., Ski, C. F., Thompson, D. R., Moore, G., Mancuso, S., Jenkins, A., Ward, G., MacIsaac, R. J., Loh, M., Knowles, S. R., Rossell, S. L., & Castle, D. J. (2016). The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomised controlled trial. Trials, 17(1), 444.


Bosanac, P., Hamilton, B., Beatson, J., Trett, R., Rao, S., Mancuso, S., & Castle, D. (2015). Mentalisation-based intervention to recurrent acute presentations and self-harm in a community mental health service setting. Australasian Psychiatry, 23(3), 277-281.

Caudle, H., Pang, C., Mancuso, S., Castle, D., & Newton, R. (2015). A retrospective study of the impact of DSM-5 on the diagnosis of eating disorders in Victoria, Australia. Journal of Eating Disorders, 3(1), 35.

Ferdowsi, N., Huq, M., Burchell, J., Mancuso, S., Tay, T., Stevens, W., Rabusa, C., Hudson, M., Sundararajan, V., & Prior, D. (2015). Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods: Abstract Number: 828. Arthritis & Rheumatology, 67, 1100-1101.

Mancuso, S. G., Morgan, V. A., Mitchell, P. B., Berk, M., Young, A., & Castle, D. J. (2015). A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: Results from the Second Australian national psychosis survey. Journal of Affective Disorders, 172, 30-37.

Mancuso, S. G., Newton, J. R., Bosanac, P., Rossell, S. L., Nesci, J. B., & Castle, D. J. (2015). Classification of eating disorders: comparison of relative prevalence rates using DSM-IV and DSM-5 criteria. The British Journal of Psychiatry, 206(6), 519-520.

Sankaranarayanan, A., Mancuso, S., Wilding, H., Ghuloum, S., & Castle, D. (2015). Smoking, Suicidality and psychosis: a systematic meta-analysis. PloS one, 10(9), e0138147.

Stolk, Y., Sevar, K., Tran, N., Mancuso, S. G., Chopra, P., & Castle, D. (2015). A comparative study of the economic and social functioning of Vietnamese-Australians with low English proficiency living with psychotic illness. International Journal of Social Psychiatry, 61(4), 319-329.


Sankaranarayanan, A., Mancuso, S., & Castle, D. (2014). Smoking and suicidality in patients with a psychotic disorder. Psychiatry Research, 215(3), 634-640.


Newton, J., Bosanac, P., Mancuso, S., & Castle, D. (2013). Bridging the gap: does a specialist eating disorder service, aimed at developing a continuum of community care, make a difference? Australasian Psychiatry, 21(4), 365-370.


Addis, S., Sherwood, D., Mace, W., Mancuso, S. G., Koloth, R., & Castle, D. J. (2012). A naturalistic study of pharmacological management of behavioural disturbance in psychosis. Journal of Psychiatric Intensive Care, 8(2), 120.

Cooper, J., Mancuso, S. G., Borland, R., Slade, T., Galletly, C., & Castle, D. (2012). Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Australian & New Zealand Journal of Psychiatry, 46(9), 851-863.

Knoesen, N. P., Mancuso, S. G., Thomas, S., Komesaroff, P., Lewis, S., & Castle, D. J. (2012). Relationship between severity of obesity and mental health: An Australian community survey. AsiaPacific Psychiatry, 4(1), 67-75.

Moore, E., Mancuso, S. G., Slade, T., Galletly, C., & Castle, D. J. (2012). The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis. Australian & New Zealand Journal of Psychiatry, 46(9), 864-878.


Phillips, B., Moulding, R., Kyrios, M., Nedeljkovic, M., & Mancuso, S. (2011). The relationship between body dysmorphic disorder symptoms and self‐construals. Clinical Psychologist, 15(1), 10-16.


Mancuso, S. G., Knoesen, N. P., & Castle, D. J. (2010). Delusional versus nondelusional body dysmorphic disorder. Compr Psychiatry, 51(2), 177-182.

Mancuso, S. G., Knoesen, N. P., & Castle, D. J. (2010). The Dysmorphic Concern Questionnaire: A screening measure for body dysmorphic disorder. Australian and New Zealand Journal of Psychiatry, 44(6), 535-542.


Mancuso, S. G., Knoesen, N. P., Chamberlain, J. A., Cloninger, C. R., & Castle, D. J. (2009). The temperament and character profile of a body dysmorphic disorder outpatient sample. Personality and Mental Health, 3(4), 284-294.

Letters to the Editor

Dean, O. M., Mancuso, S. G., Bush, A. I., Copolov, D., Do, K. Q., Cuenod, M., Conus, P., Rossell, S. L., Castle, D. J., & Berk, M. (2015). Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia. Psychiatry Research, 230(3), 982-983.

Book Chapters

Mancuso S, Phillipou A, Rossell S, Castle DJ. Body image disorders in women. In: Abel K, Castle D (eds). Comprehensive women’s mental health. Cambridge University Press: Cambridge, 2016, pp 197-207.

Moulding R, Mancuso SG, Rehm I, Nedeljkovic M. The self in the obsessive–compulsive-related disorders: hoarding disorder, body dysmorphic disorder, and trichotillomania. In: Kyrios M, Bhar S, Doron G, Mikulincer M, Moudling R, Nedeljkovic M (eds). The self in understanding and treating psychological disorders. Cambridge University Press: Cambridge, 2016, pp 123-133.